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 Proper nervous system development is required for an organism’s survival and function. Defects 
in neurogenesis have been linked to neurodevelopmental disorders such as schizophrenia and autism 
spectrum disorders.  Understanding the gene regulatory networks that orchestrate neural development, 
specifically cascades of proneural transcription factors, can better elucidate which genes are most 
essential in governing early neurogenesis. Neurogenins are a family of such factors that are both 
sufficient and necessary for the development of neural sub-types in mice, primarily through the 
regulation of other factors, particularly NeuroD.  The objective of this study was to evaluate previously 
established regulatory targets of neurogenin (ngn-1) and to identify unknown downstream targets, 
using the nematode Caenorhabditis elegans as a model for these studies. We find that in C. elegans, 
neurogenin is required for axon outgrowth, cell fate specification, and epithelial integrity during 
embryonic development. Using RNA sequencing and comparative transcriptome analysis we found that 
ngn-1 acts primarily to repress transcription, facilitating proper embryogenesis.  We also identified 
specific candidates for activation by ngn-1, including hlh-34(NPAS1) and unc-42(Prop1), which we 
further validated using genetic methods.  Our results identify novel pathways connecting ngn-1 to 
known terminal regulators, which maintain cell fate of terminally differentiated neural subtypes, and 







CHAPTER 1 - Introduction 
 The development of the nervous system begins in early embryogenesis through spatial and 
temporal changes in gene expression orchestrated by proneural transcription factors. A single cell gives 
rise to neuroectodermal tissue, which involutes to form the neural tube then differentiates to form the 
diversity of cells that make up the human brain. Defects during nervous system development can be 
detrimental, and are implicated in disorders such as autism spectrum disorder (ASD) and schizophrenia 
(Ho et al., 2008; Xiao et al., 2014). While some genetic mutations have been causally linked to these 
disorders, such as mutations in the Shank3 scaffold protein, there is no single genetic cause for the 
majority of ASD or schizophrenia cases. (Happé et al., 2006; Stachowiak et al., 2013; Zhou et al., 2016). 
Genome-wide association studies indicate that polymorphisms linked to ASD and schizophrenia often 
map to non-coding regions of the genome (Freitag, 2007; Ripke et al., 2011). These findings suggest that 
some neurodevelopmental disorders are the result of changes in a gene regulatory network consisting 
of multiple factors, including transcriptional regulation and epigenetic effects (Guillemot and Hassan, 
2017). Epigenetic regulators that control DNA compaction and RNA polymerase accessibility work in 
parallel with transcription factors to repress or activate the transcription of target genes, however the 
way transcription factors function in relation to each other and with these chromatin modifying 
complexes is not well understood (Hirabayashi and Gotoh, 2010). The aim of this project is to 
understand how transcription factors control nervous system development and function, with a 






Neurogenin - a neuronal determination gene 
 Some of the earliest acting regulators of neurogenesis are the neurogenin genes, which code for 
a family of basic-helix-loop-helix (bHLH) transcription factors (Yuan and Hassan, 2014). These proteins 
form obligate heterodimers, bind to the cis-regulatory promoter regions of other genes, and aid in 
either enhancing or suppressing transcription (Grove et al, 2009). The “basic” region of bHLH 
transcription factors binds to the specific promoter motif “CANNTG”, which is also called an E-box (Fig. 
1B) (Massari and Murre, 2000).  This basic region contains multiple lysine and arginine residues, and 




Figure 1. Neurogenins are highly conserved bHLH proteins.  A) An illustration of a dimerized neurogenin protein bound to an E-box. 
B) An example of a bHLH binding motif, in this case, that bound by C. elegans CND-1/HLH-2 (JASPAR, 2018). C) The highly 
conserved bHLH region of neurogenin proteins of different species. Image generated using Jalview.org  (Waterhouse et al., 2009) 
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 The first published research on neurogenins found that it has pro-neural functions in cell 
determination and likely functions near the top of a fate specification regulatory cascade (Ma et al., 
1996). Injection of mouse Neurogenin mRNA into Xenopus embryos caused ectopic neurogenesis in 
ectodermal tissue. Additionally, neurogenin caused the ectopic transcription of NeuroD, another pro-
neural bHLH. This finding, as well as the expression of neurogenin at an earlier developmental stage in 
multiple organisms, indicates NeuroD as one of the primary downstream targets of neurogenin (Fode et 
al., 1998; Sommer et al., 1996). 
 Mammals have three neurogenin genes; two are active in the brain during neural development, 
and a third (Ngn3) is required for the development of pancreatic tissue and insulin-secreting cells (Gu et 
al., 2002). Research on murine neurogenins in cell culture found that Ngn1 promotes neurogenesis, but 
also actively inhibits astrocyte differentiation (Sun et al., 2001).  Mouse embryos with a homozygous null 
mutation in the proneural gene Ngn2 have few morphological defects, yet development defects were 
observed in the forebrain, dorsal root ganglia, and distal cranial ganglia as identified using neurofilament 
protein (NF-M) antibody staining and a cRNA probe for SCG10, a late pan-neuronal marker (Fode et al., 
1998). Ngn2 mutant mice were unable to feed normally, exhibited a low level of activity, and generally 
died within one day of birth.  None of the animals studied were able to survive more than 25 days.  
 In addition to their proneural fate determination function, neurogenin genes are also required 
for dendritic development and axon guidance (Hand and Polleux, 2011). Ngn2 null mutant mice were 
found to have defective axon targeting in the corpus callosum, aberrant projections across the midline, 
and defasciculation of axons. In the invertebrate model Drosophila melanogaster, knockdown of the 
neurogenin ortholog Tap caused axon extension and guidance defects in the fly midbrain. Additionally, 
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germline injection of Drosophila derived Tap mRNA into Xenopus embryos was sufficient to stimulate 
neurogenesis from epithelial tissue (Yuan et al., 2016).   
 In humans, studies of neurogenin 1 found associations with multiple neurodevelopmental  
disorders.  Two single nucleotide polymorphisms associated with schizophrenia fall within the regulatory 
region of the neurogenin 1 locus (Fanous et al., 2007). In another report, a patient with congenital 
cranial dysinnervation disorder, a neurological condition characterized by facial paralysis including 
hearing loss and lack of facial expression, was found to have a homozygous deletion of the entire 
neurogenin 1 gene (Schroder et al., 2013). Mutations in neurogenin 3 have been associated with cases 
of diabetes and congenital malabsorptive diarrhea due to a loss of key endocrine cells in the intestine 
(Germán-Díaz, 2017; Rubio-Cabezas et al., 2011; Rubio-Cabezas et al., 2016; Sayar et al., 2013). In 
another study, patients with homozygous mutations in neurogenin 3 were also diagnosed with 
hypogonadotropic hypogonadism, a disorder characterized by improper function of the pituitary gland.  
 Aside from NeuroD, the downstream regulatory targets of neurogenin are not well understood. 
One possible regulatory target is the Notch-inhibitor ligand Delta protein like 1 (Dll1).  Studies in 
Xenopus embryos found that neurogenin induced transcription of Dll1, which controls a choice between 
neuronal and non-neuronal fates (Ma et al., 1996). In a genome-wide study in Xenopus, multiple 
strategies were used to identify likely targets of neurogenin, including computational analysis of E-box 
binding motifs, DNA microarray, and RT-qPCR (Seo et al., 2007).  Predicted targets covered multiple 
functional areas including transcriptional regulation, signal transduction, neuronal differentiation, and 
cell migration. Despite this, almost half of the transcribed loci identified were of unknown function.  The 
severity and high variability of neurogenin mutant phenotypes, as well as the apparent complexity of 
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neurogenin transcriptional regulatory networks, demonstrate the need for greater understanding of 
neurogenin function during nervous system development.  
 
C. elegans as a neurodevelopment model 
 The nematode Caenorhabditis elegans was first characterized as a model organism for the study 
of genetics (Brenner, 1974). A quick life cycle, ease of maintenance, the ability to freeze strains, and a 
fully sequenced genome make it one of the most common models in research, particularly in 
neuroscience and developmental biology. Additionally, C. elegans are transparent, and adult nematodes 
have an invariant cell lineage, with 302 neurons, allowing for the study of very early embryonic 
development (Corsi et al., 2015). Embryos can be harvested at the single-cell stage, and individual cell 
movements throughout embryogenesis can be tracked and analyzed using time-lapse differential 
interference contrast (DIC) microscopy, or with fluorescent histone reporter genes.  Within the last ten 
years, numerous papers have supported the use of C. elegans as a model for both neurodevelopment 
and autism spectrum disorders specifically (Calahorro and Ruiz-Rubio, 2011; Schmeisser and Parker, 
2018; Wang et al., 2017).  
 Given its early expression in embryonic development, and the broad and variable phenotypes 
observed in ngn-1 mutants, we hypothesized that ngn-1 has downstream regulatory targets that have 
yet to be defined. To investigate this hypothesis, we used two primary approaches; a candidate gene 
approach using classical genetic methods, and transcriptome generation and analysis. Using these tools, 
the aim of this project is to identify and validate novel gene targets of ngn-1 regulation and understand 




CHAPTER 2 - A candidate gene approach to understanding neurogenin transcriptional regulation 
Introduction 
 The C. elegans genome contains a single neurogenin ortholog, ngn-1. Worms bearing a 
homozygous null mutation in ngn-1 have a sluggish phenotype, as well as a tendency to coil when 
moving forwards (Wormbase.org). ngn-1 has previously been studied in C. elegans to investigate its role 
in proneural differentiation (Nakano et al., 2010). ngn-1 loss-of-function caused a cell fate change of the 
MI pharyngeal neuron to an epithelial cell similar to the e3D, supporting previous studies implicating 
ngn-1 as a proneural gene.  While these findings indicate that ngn-1 acts proneurally to determine 
neuronal cell fate in some contexts, no paper has been published focusing on its role in axon outgrowth 
and guidance in C. elegans. 
 A fairly comprehensive analysis of all of the bHLH transcription factors in C. elegans found that 
ngn-1 dimerizes with only one other bHLH, HLH-2 (human TCF3/E47), and does not form a homodimer 
(Grove et al., 2009). These bHLH heterodimers bind to highly-conserved DNA regions called E-boxes, 
usually in cis-regulatory regions upstream of target genes (Fig. 2B). The canonical E-box binding motif is 
‘CANNTG’, where ‘N’ represents any nucleotide. The specific E-box binding motif(s) of the NGN-1/HLH-2 
dimer were unable to be determined in a study testing all possible permutations, despite success 
identifying the motifs of other dimers (Grove et al., 2009). One possibility for this is NGN-1 binding to 
non-canonical E-boxes, which could limit the use of motifs in evaluating regulatory targets of ngn-1. 
 Published data regarding ngn-1 expression in C. elegans is limited, however expression of ngn-1 
was found to be greatest during early embryogenesis and then restricted to a few head neurons and gut 
cells post-hatching (Nakano et al., 2010). When the worm is fully enclosed in epithelium and beginning 
to elongate (approximately 430 minutes post fertilization), ngn-1 is expressed almost exclusively in the 
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anterior embryo, and shows substantial overlap with its binding partner HLH-2 (Grove et al., 2009).  The 
lineage of ngn-1 expression is unknown. 
 Based this knowledge, the purpose of this project is to identify target genes that are regulated by 
ngn-1. First, we sought to further characterize the effect of ngn-1 loss of function in the C. elegans 
nervous system. Next, we used a candidate gene approach and classical genetics tools, including loss-of-
function mutants and transgenic reporters, to investigate possible regulatory targets of ngn-1. 
 
CHAPTER 2 - Methods  
C. elegans strain construction and maintenance 
C. elegans strains were grown on nematode growth medium plates (NGM Lite) at 20°C as described 
previously (Brenner, 1974). N2 (Bristol) was used as the wild-type strain. Table 1 shows a list of mutant 
strains used in this project.  
Strain Gene Allele 
VC2084 ngn-1 ok2200 
CZ1455 cnd-1 ju29 
VC1560 cnd-1 gk718 
CZ337 vab-1 dx31 
EM305 efn-4 bx80 
RB712 daf-18 ok480 
AH205 sdn-1 zh20 
CX3198 sax-3 ky123 
IC476 sax-3 ky123; quEx99 [sax-3(minigene) + odr-1::RFP] 
EM67 mab-20 bx24; him-5(e1490) 
 
Table 1. Mutant strains used in this project. Strains were sourced from either the Caenorhabditis Genetics Center or by request from 
individual PIs. 
All mutants were outcrossed to a minimum of 4x except for gk718(2x), dx31(1x), ok480(2x), and 
ky123(3x). For a list of strains generated for this project, see supplemental table - S1. 
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GFP neuronal expression imaging 
 For candidate gene crosses, wild-type and loss of function mutants were crossed into the 
following neuronal expression strains: OH904 otIs33 [pkal-1::GFP], OH99 mgIs18 [pttx-3::GFP] and 
CZ1200 juIs76 [punc-25::GFP]. Adult worms were staged for imaging by transferring 10-20 L4 
hermaphrodites to a new plate and imaging those worms 24 hours later. Adult worms were mounted on 
2% agarose pads, anesthetized with 3.5μl of 10mg/ml sodium azide solution, and then immobilized 
under an 18x18mm cover slip. Adult worms were imaged using either a Zeiss LSM 700 confocal 
microscope with Zen Black imaging software, or a Zeiss AxioImager Z2 fluorescent microscope with Zen 
Blue imaging software. Images were analyzed using ImageJ (Fiji) software (Rueden et al., 2017; 
Schindelin et al., 2012). 
 
Characterization of neuronal morphology in candidate genes 
 Head neuron and nerve ring morphology in otIs33 [pkal-1::GFP] expressing worms was scored by 
counting the number of GFP positive cell bodies in three distinct regions of the head: the corpus, the 
isthmus, and the terminal bulb of the pharynx. Percentages of cell bodies by region were compared to 
wild-type worms and statistical analysis was performed using the Fisher exact test.  
 AIY morphology was visualized using the mgIs18 [pttx-3::GFP] transgene in young adult 
hermaphrodites. Cell bodies were considered anteriorly displaced if the entire cell body was anterior to 
the anterior end of the terminal bulb. Axon length was scored by measuring the length of each axon 
from the plexus to the dorsal gap junction and averaging the axon length for each genotype. Statistical 





 L4 hermaphrodites were single-plated on NGM Lite plates. After 24 hours, each hermaphrodite 
was transferred to a new plate. 24 hours after the removal of the hermaphrodite, each plate was scored 
for dead embryos and live L1/L2 larvae. The plates were rescreened 48 hours later for live adults, and 
the number of adults was subtracted from the L1/L2 larval counts to determine larval lethality. Adults 
were transferred until they died or until no more viable embryos were observed. Dead embryo and 
larvae counts were compared to wild-type worms and statistical analysis was performed using Fisher’s 
exact test.  
  
Embryo mounting for time-lapse microscopy 
 Two or four cell embryos were obtained through dissection of young adult hermaphrodites. 5-10 
worms were placed in a watch glass filled with M9, and each worm was cut in two approximately at the 
vulva using a no. 10 blade scalpel. Desired embryos were transferred via mouth-pipette to a freshly 
made 2% agarose pad and grouped into clusters of embryos using an eyelash pick. Some of the M9 was 
removed until the embryo cluster was just barely covered, and an 18x18mm cover slip was laid gently 
onto the pad. The agarose pad was trimmed flush with the cover slip on all 4 sides, and a small drop of 
immersion oil was placed at each of the 4 corners of the coverslip to seal the sample. This assay was 
most successful using Zeiss ImmersolTM W. 
 
Time-lapse microscopy of embryonic development 
 4-dimensional microscopy assays were carried out using a Zeiss AxioImager Z2 fluorescent 
microscope equipped with motorized z-axis stage.  High resolution DIC images were collected using a 
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63x magnification oil immersion objective. A series of 1µm steps (27–30 slices) were captured every 2 
minutes for 300 cycles using Zen Blue software. Images were analyzed via ImageJ (Fiji) software. The 
following developmental time points were scored: Ea/Ep cell ingression, gastrulation cleft opening, 
gastrulation cleft closure, ventral enclosure, comma stage, and elongation. Scores for mutant strains 
were compared to wild-type worms and statistical analysis was performed using student’s t-test. 
 
 
CHAPTER 2 - RESULTS  
ngn-1 mutant phenotypes indicate a role in transcriptional regulation across multiple systems 
 As there is little data published on ngn-1 in C. elegans, we first sought to characterize ngn-1 
mutant phenotypes in worms and to validate previously published phenotypes in other organisms, such 
as axon guidance and outgrowth defects (Hand and Polleux, 2011; Yuan et al., 2016).  We obtained an 
ngn-1 null mutant allele, ok2200, which contains a 2266bp deletion encompassing the second and third 
exon, and an insertion of the sequence: AGAGACA (Fig. 2A).                                                                           
Figure 2. A) The ngn-1 gene is located on chromosome IV. The ok2200 mutation is a 2266bp deletion that removes most of the gene 
including the predicted DNA binding domain, hence is likely to be a null allele.  B) An example of typical bHLH transcription factor 
binding. NGN-1 forms an obligate heterodimer with another bHLH transcription factor, most likely HLH-2, and binds to DNA at E-boxes 





 The most striking phenotype we observed while maintaining ngn-1 mutants aside from a general 
sluggishness, was their decreased ability to clear food from a plate. Plates of ngn-1 worms needed to be 
transferred onto new plates much less often than other strains. To better understand this, single L4 
hermaphrodites of wild-type and ngn-1(ok2200) were plated on a fresh food plates and imaged every 24 
hours for 7 days.  We observed that the field of bacteria on ngn-1 mutant plates is cleared slowly, and in 
a gradient across the food pad, when compared to wild-type (Fig. 3).  In other words, on one side of the 
plate worms would be clumped up on bare agar (a sign of starvation) and on the other side there would 
be relatively untouched patches of food. This could be caused by multiple issues including embryonic 




Figure 3. Time-lapse of wild-type and ok2200 mutants on a standard OP50 food pad. A single L4 hermaphrodite was placed on each plate 
(white arrowhead) and imaged every 24 hours. ok2200 mutants show limited individual range and by day 7, some worms lie starving on the 
upper right corner of the plate while there is still food available in the bottom left corner. 
 
 To investigate whether ngn-1 mutants had embryonic lethality, we scored whole broods of ngn-1 
mutants for embryos that never hatched and larvae that died before reaching adulthood.  ngn-
1(ok2200) mutants were found to be 45.9% embryonic lethal (Fig. 4A). Because ngn-1 is a proneural 
gene, this lethality may indicate errors in early embryonic development, such as the failure to activate 
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transcription of genes required for proper neuroblast migration. Additionally, these data indicates that 
embryonic lethality is contributing to defective food-clearing, though it does not rule out other factors 
such as food sensing, nutritional processing, or neuromuscular movement defects. We did observe 
other phenotypes including aberrant head movements and egg laying defects that were not investigated 
for this project. 
 To determine when ngn-1 mutants were dying during embryonic development, we conducted 
time-lapse (4D) confocal microscopy to observe developing ok2200 embryos from 2-4 cells though to 
hatching stage. Surprisingly, we did not observe any obvious neuroblast migration defects (Fig. 4B-C). 
Instead, the main defect observed in arrested embryos was a posterior ventral rupture during        
elongation, when the worms are essentially fully formed. As mentioned previously, ngn-1 is expressed 
primarily in the head, so a posterior rupture was unexpected. This would suggest that ngn-1 is either 
regulating posterior epithelial integrity at an earlier time point by working through downstream factors, 
or that ngn-1 is somehow regulating this activity non-cell autonomously. 
 While fewer (33%) embryos arrested during 4D imaging, this discrepancy is likely the result of 
selection bias due in part to the nature of this assay.  In order to obtain 2 or 4 cell embryos for 
mounting, hermaphrodite worms visibly full eggs are selected for embryo extraction. These worms 
typically appear more “healthy.” We have observed that some ngn-1(ok2200) worms may appear 
smaller, thinner, and just generally “sicker” than others, and are therefore these worms were likely not 
chosen for this assay.  We have also observed 2 to 12 cell embryos on the plate. This suggests a 
premature egg laying defect, as wild-type embryos are laid at the 20-30 cell stage.  These observations, 




 To begin to understand the role of ngn-1 in the development of nervous system, ngn-1(ok2200) 
mutants were crossed with the transgene otIs33[pkal-1::GFP], which expresses green fluorescent 
protein (GFP) in numerous neurons throughout the body.  In comparing this strain to wild-type worms, 
we found that ngn-1 mutants have a highly disorganized nerve ring, with numerous displaced cell bodies 
and aberrant dendritic projections (Fig. 5). Additionally, some of the ngn-1 mutants have a broad nose 
compared to wild-type; the reason for this is not known. We characterized the cell body displacement 
phenotype by counting the number of GFP positive cell bodies in three distinct regions of the head: the 
corpus, the isthmus, and the terminal bulb. Percentages of cell bodies by region were compared to wild-
type worms, and ngn-1 mutants had substantial anterior displacement of head neurons, with nearly half 
of the neurons positioned in the corpus where there should be zero (Fig. 5E).  
Figure 4 
Figure 4. ngn-1(ok2200) mutants are 45% embryonic lethal. A) Percentage of offspring that failed to hatch 24hrs post-laying. Black 
dots represent individual broods scored. n values listed in Table 3. ***p≤0.0001. B) 25% of ngn-1 mutant embryos arrested during 
elongation.  C-D) wild-type and ngn-1 mutant embryos imaged at 2-fold stage during embryogenesis.  Images are a right lateral view, 
with the ventral surface of the worm located toward the interior. Open arrow indicates the ventral posterior surface of a wild-type 





 As it was difficult to characterize the axon defects in these worms with a large number of GFP-
expressing cells and severe disorganization, we crossed ngn-1(ok2200) mutants into a GFP transgene 
expressed in only a single pair of cells - - the AIY interneurons. Confocal images of these strains were 
analyzed for displacement of cell bodies, missing cell bodies, and axon defects. Nearly all of the ok2200 
mutants showed both anteriorly displaced neurons and defects in axon outgrowth from the ventral 
plexus (Fig. 6C-E,6G-H). The average ventral to dorsal axon extension was only 13.4m from the ventral 
plexus, where the AIY axons come near each other, to where they should form a gap junction on the 
dorsal side of the pharynx. Most ok2200 axons did not extend over the pharynx, and none made contact 
with their transverse pair. In contrast, the average extensions of wild-type and ngn-1+rescue worms 
were 27.9m and 31.0m, respectively, and these axons showed no defects in dorsal L-R cell 
connections. Taken together, these defects suggest that ngn-1 likely regulates axon guidance genes 
including secreted guidance cues, cell-membrane receptors, and extracellular matrix proteins.  
 
Figure 5. A-D) Confocal imaging of otIs33[pkal-1::GFP] expressing worms at 40x. All images are a left lateral view, with anterior to the left. 
Arrow indicates the nerve ring. ngn-1 null mutants have a disorganized nerve ring, with severe cell body displacement and axon defects. 





 In 16% ok2200 mutants only one GFP-expressing AIY neuron was observed. This could be the 
result of one of two possibilities: 1) both AIY neurons are still present and one cell has lost ttx-3::GFP 
expression, or 2) one cell body is missing or has altered cell-fate specification. The first is unlikely as ttx-3 
is a terminal regulator of the AIY interneurons, meaning it is continually expressed in AIYs throughout 
the life of the worm and is likely required for the maintained of terminal AIY cell-fate. Therefore, if ttx-3 
expression were lost in these cells, they would no longer be AIY neurons. As such, this data suggests that 
these “missing” cells have somehow failed to differentiate into AIY neurons, indicating that ngn-1 is 
Figure 6. Confocal images of mgIs18[pttx-3::GFP] expressing worms at 40x. All images are a left lateral view, with anterior to the left. 
The pharynx is outlined in grey. A) An illustration of the AIY interneurons from Wormbase.org. B) Wild-type morphology of the AIY 
neurons. C&D) Examples of ok2200 AIY axon outgrowth defect in AIY neurons.  The defects in D) are more severe. E) 16% of ok2200 
mutants showed a single GFP-expressing neuron (p≤0.05). F) Rescue of the ok2200 anterior displacement and axon outgrowth defects 
using the rescuing transgene nIs394 [ngn-1::GFP + lin-15(+)]. G-I) Scoring data for average axon length, anterior displacement, and 








functioning as a proneural gene in certain C. elegans neurons, consistent with previous research in 
vertebrates. 
 
ngn-1 may regulate some terminal effector candidate genes during embryogenesis  
 In our initial attempt at identifying regulatory targets of ngn-1, we began by selecting candidate 
genes base on the phenotypes we observed the ok2200 mutants.  A review of the literature led to the 
selection of the following targets shown in Table 2. 
 
Candidate Genes Phenotype Category Source 
cnd-1 (NeuroD1) Downstream in vertebrates bHLH transcription factor Ma et al., 1996 
daf-18 (PTEN) AIY extension defects intracellular effector Christensen et al., 2011 
sdn-1 (syndecan) AIY extension defects cell surface HSPG Hudson et al., 2006 
vab-1 (ephR) Ventral plexus gap cell surface receptor Schwieterman et al., 2016 
efn-4 (ephrin) AIY extension defects extracellular ligand Schwieterman et al., 2016 
mab-20 
(semaphorin) 
Axon guidance defects extracellular guidance 
cue 
Wang et al., 2008 
sax-3 (Robo) Anterior shift, axon defects  Transmembrane 
receptor 
Zallen et al., 1998 
 
Table 2. Candidate axon guidance genes and/or predicted downstream regulatory targets of neurogenin, based on the axon 
outgrowth phenotypes observed in ngn-1(ok2200) mutants   
 
To determine whether of ngn-1 may be regulating these genes during development, we began 
by duplicating the previous lethality assays for mutants of each of the candidate genes. Additionally, we 
generated double mutants containing each of the candidate genes in the ngn-1(ok2200) mutant 
background. Overall, the majority of the double mutant strains showed enhanced embryonic lethality 
over ngn-1 alone, and the increase in lethality was proportional to the respective candidate mutant’s 
lethality (Table 3). For example, the ngn-1; efn-4 double mutant was 60.1% embryonic lethal, and this 





Genotype Lethality - Percent Average (SD) Broods N 
 Embryonic Lethality Larval Lethality   
wild-type† 0.11 (0.2)** 0.12 (0.2)* 4 823 
ngn-1(ok2200) 45.9 (4.8) 10.2 (2.2) 3 482 
cnd-1(ju29)† 1.5 (1.4)** 1.0 (1.2)* 4 783 
ngn-1; cnd-1(ju29) 45.5 (6.1) 26.1 (5.2)* 8 1967 
cnd-1(gk718) 7.9 (1.4)** 12.4 (2.0) 6 1464 
ngn-1; cnd-1(gk718) 51.7 (5.5) 18.7 (1.1) 6 851 
daf-18(ok480) 3.3 (1.0)** 0.3 (0.5) 6 1586 
ngn-1 daf-18(ok480) 64.3 (5.4)* 17.1 (5.6) 4 715 
sdn-1(zh20)† 7.7 (5.3)** 5.5 (3.7)  868 
ngn-1; sdn-1(zh20) 11.8 (8.5)** 10.4 (5.9) 5 656 
efn-4(bx80) 14.2 (2.6)** 8.0 (3.3) 6 927 
ngn-1 efn-4(bx80) 60.1(15.3)* 13.1(1.9) 3 389 
mab-20(bx24) 15.2 (7.2)** 5.0 (4.1) 5 905 
ngn-1 mab-20(bx24) 32.3 (7.3) 3.1 (1.0) 5 1510 
vab-1(dx31) 6.7 (5.0)** 18.4 (4.1) 5 763 
ngn-1; vab-1(dx31)‡ - - - - 
sax-3(ky123) 70.1 (17.2)** 10.3 (8.2) 3 635 
ngn-1; sax-3(ky123)‡ - - - - 
ngn-1 + Rescue in progress    
 
Table 3. Embryonic and lethality of ngn-1(ok2200) and candidate gene crosses by genotype. † data included with permission from Martin L. 
Hudson. ‡ unable to build strain, likely synthetic lethal. * indicate significantly different from ok2200, p≤0.05. ** indicate significantly 
different from ok2200, p≤0.001 
 
 
were relatively similar for both of the cnd-1 mutant alleles. The ngn-1; daf-18 double mutants produced 
a synergistic lethality more severe than their individual mutations, indicating that daf-18 may fall in a 
parallel pathway not regulated by ngn-1. Two candidates, mab-20 and sdn-1, showed a decrease in 
lethality when crossed with ngn-1(ok2200). While it is possible that these mutations may partially rescue 
the effects of ngn-1 loss-of-function, we are currently validating this data with additional experiments 
 In order to determine if ngn-1 regulates any of the candidate genes in the development of the 
nervous system, we generated single and double mutant strains containing the AIY GFP reporter.  
Overall, the average axon lengths of candidate gene single and double mutants suggest that the ok2200 
phenotype likely masks defects in the double mutants (Fig.7A). Aside from cnd-1 and vab-1, most of the 
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candidate genes were previously shown to have varying degrees of outgrowth defects in AIY or other 
neuronal sub-types (Christensen et al., 2011; Hartin et al., 2015; Schwieterman et al., 2016; Wang et al., 
2008).  Though the axon lengths shown here are similar to wild-type, the AIYs in a percentage of these 
mutants fail to connect via the dorsal gap junction (Fig 7B).   
  The axon lengths in each of the ok2200-containing double mutants is significantly 
decreased from their individual mutant strains (Fig. 7A). This suggests that the ngn-1 mutant phenotype 
is so severe that it masks the effect of the candidate gene outgrowth defects. In fact, many of the 
double mutant images were difficult to score due to this severity. Overall, we found no conclusive 
evidence of increased axon outgrowth defects in candidate gene double mutants, although we cannot 
rule out that ngn-1 may be in the same neurodevelopmental axon outgrowth pathway as one or more 
of the candidate genes listed above.  
 
  
Figure 7.  AIY axon outgrowth defects in ok2200 and candidate single and double mutants. A) Average axon lengths of candidate gene 
single and double mutants containing the mgIs18[pttx-3::GFP] AIY reporter. B) 100% of all double mutants containing ok2200 lacked 
complete AIY interneuron connection. Error bars indicate standard error of the mean (n=20+).  *p≤0.05, **p≤0.001, ***p≤0.0001 
Figure 7 
40x. All images are a left lateral view, with anterior to the left. A and C) wild-type strain. B and D) 
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CHAPTER 2 - DISCUSSION  
C. elegans ngn-1 controls multiple developmental processes 
 The data described in this chapter characterizes the mutant phenotypes of the transcription 
factor gene ngn-1 in C. elegans. By examining these phenotypes in a null loss-off-function mutant, we 
can begin to understand the gene regulatory cascade of ngn-1 and identify possible targets of 
transcriptional regulation. The substantial embryonic lethality of ok220 mutants (45.9%) coupled with 
difficulty in food clearing suggests systems that ngn-1 may be required in multiple neurodevelopmental 
regulatory pathways, such as those required for correct assembly of sensory neuronal circuits, 
neuromuscular circuits, and cell differentiation and specification during embryogenesis. Previous work 
in mice described neurogenin 2 (Ngn2) homozygous mutants as having abnormal limb posturing, 
lethargy, and the inability to feed properly, as evidenced by their stomachs being empty when they died 
within the first day of life (Fode et al., 1998). Our results are consistent with these findings.  Additionally, 
the study suggests embryonic lethality of Ngn2 -/- mice based on offspring genotype ratios.  
 We also find that ngn-1 is at least partially required in C. elegans for AIY axon outgrowth. Again, 
these data are consistent with previous research in other organisms. Research on the Drosophila ngn-1 
ortholog Tap found that this gene is required for proper axon outgrowth and targeting from the α to β 
lobe, and that Tap knockdowns had aberrant axon extensions across the midline (Yuan et al., 2016). 
Another study found that Ngn2 mutant mice also have abnormal axon crossing over the midline in the 
corpus callosum, with axons defasciculating before reaching the midline (Hand and Polleux, 2011).  
 ngn-1 has previously been shown to have a proneural function in the specification of the C. 
elegans pharyngeal neuron M1 (Nakano et al., 2010).  Here we show that ngn-1 loss-of-function leads to 
a suspected fate specification defect in AIY interneurons. Taken together these findings suggests that 
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ngn-1 functions proneurally, at least in some cell sub-types, to regulate differentiation of the nervous 
system. Additionally, this aligns with our understanding of the roles of neurogenin genes in vertebrates, 
where there has been substantial work investigating their proneural functions in the determination and 
specification of regions of cranial sensory ganglia, dorsal root ganglia, olfactory bulb neurons, and 
glutamatergic neurons in the ventral midbrain (Kele et al., 2006; Ma et al., 1998; Ma et al., 1999; Shaker 
et al., 2012). This is in contrast, however, to the study in Drosophila, which concluded that while Tap/ 
ngn-1 does regulate axon outgrowth, it is not required for neural or glial specification (Yuan et al., 2016). 
Understanding the extent and specificity of the proneural function of ngn-1 in C. elegans requires 
further investigation. 
 
ngn-1 likely does not directly regulate terminal candidate genes  
 Based on our findings, the majority of the candidate genes investigated for this project are likely 
not directly regulated by ngn-1 in pathways related to embryonic viability. Additionally, we found no 
conclusive evidence that ngn-1 regulates any of these candidates in axon outgrowth pathways. The 
guidance defects in some of the ngn-1(ok2200) mutants were so severe that it was often difficult to 
measure axon lengths in the double mutants. It is important to note that we only evaluated lethality, 
and  a single neuronal cell-type, and that other C. elegans neurons may be more sensitive to ngn-1-
dependent transcriptional regulation. 
 The candidate genes investigated for this project were chosen based on phenotype similarity to 
the most striking of ngn-1 mutant phenotypes - - embryonic lethality and axon outgrowth. However, the 
majority of these genes carry out functions in a terminally differentiated cell and are not developmental 
transcription factors. Our lack of any conclusive evidence of regulation by ngn-1 is in agreement with a 
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proneural transcription factor regulatory cascade model and are consistent with our hypothesis that 























CHAPTER 3 – Using comparative RNAseq analysis to unravel neurogenin transcriptional regulation 
INTRODUCTION 
 Neurogenins are proneural transcription factors that activate a cascade of other transcription 
factors to regulate cell determination and specification across multiple vertebrate systems (Murtaugh 
and Kopinke, 2002; Yuan and Hassan, 2014).  This cascade allows for both greater specificity of action, as 
well as the amplification of the regulatory signal (Phillips, 2008). A transcription factor cascade consists 
of multiple levels of gene activation and repression, often including self-regulation and co-regulation, 
which end in the expression of terminal effectors responsible maintenance and function of specific cell 
or tissue types, as illustrated in the model shown in Figure 8. Collectively, the terminal outputs of this 
cascade, which may interact with or mask one another, generate the overarching effect of the primary 
transcription factor, allowing for a single protein to have broad reaching effects across multiple systems. 
This transcription factor cascade model offers an 
explanation of the pleiotropy seen in C.elegans 
ngn-1 mutants. As described in Chapter 2, ngn-1 
mutants have defects across multiple systems 
including missing neurons (neural cell-fate 
specification), axon guidance defects (cell-to-cell 
communication), and embryo rupture (epithelial 
integrity, cell migration, or cell fate specification). 
A reverse genetic screen for individual 
phenotypes would likely lead to the identification 
Figure 8 





of terminal genes, and possibly even the transcription factors directly upstream of those genes. 
However, pleiotropy and the possibility for epistasis make unraveling the full regulatory network of an 
early-acting transcription factor via phenotypic analysis unlikely.  
 
RNAseq and Transcriptomics 
 The development of next-generation sequencing, and its steady reduction in cost have allowed it 
to become a regular tool in developmental and molecular biology. RNA sequencing (RNAseq) is able to 
both identify and quantify gene expression, essentially creating a gene expression snapshot at a given 
point in time. This is accomplished through a series of steps illustrated in Figure 2. First, total RNA is 
isolated from a sample. Both the developmental stage and tissue-type of the sample allow for specificity 
depending on the experimental 
question. Next, a cDNA library is 
generated through reverse-
transcription, and the cDNA is 
processed, labeled, and sequenced in 
short segments anywhere from 75-
150bp in length. This generates a 
large dataset of millions of sequences 
called reads, which can be analyzed 
using numerous software tools that 
have been developed specifically for 
analysis of large genetic datasets 
Figure 9 
Figure 9. An illustration of a genome-based RNA-sequencing and analysis 
workflow. Image adapted from Mcqueen et al., 2015. 
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(Conesa et al., 2016; Liao et al., 2014; Love et al., 2014). Reads can be aligned to their corresponding 
segment of a known genome and then mapped to the exons of annotated genes. Based on these 
alignments, a count of the number of transcripts per gene is generated. Comparisons can be made 
between the mutant and wild-type gene counts, using negative binomial distribution statistics, allowing 
for the identification of differentially expressed genes in the experimental data set. (Mcqueen et al., 2015) 
 Our approach for this project was to use RNA-sequencing and computational analysis to identify 
transcription factors that are directly regulated by ngn-1 by comparing the embryonic transcriptional 
profiles of ngn-1 mutants with that of wildtype embryos.  This unbiased approach will allow for the 
characterization of the overall ngn-1 gene regulatory network, including non-neuronal factors, as well as 
the identification and validation of transcription factors that regulate the development of the nervous 











Chapter 3. METHODS  
RNA extraction and sequencing 
 ngn-1(ok2200) mutants and wild-type hermaphrodites were grown in liquid culture in 25cm x 
25cm trays.  Liquid culture media consisted of M9 buffer, 1mg/ml cholesterol, and OP50 E. coli. 
Approximately 5ml of OP50 slurry was added daily.  When most of the worms were gravid adults 
(approximately 1.5 days), embryos were isolated by pelleting worms and resuspending in Death Buffer 
(1.2% NaOCl in 0.5M NaOH) until only embryos remained, then washed(3x) and resuspended in M9 
buffer.  200-300μl of embryos were added to a mortar containing liquid N2 and ground to break the 
chitinous eggshell. A separate mortar and pestle were used for each strain. 
  RNA was extracted via liquid-liquid extraction using RiboZol and chloroform in MaXtract High 
Density tubes (Qiagen, Germantown, MD).  The aqueous phase containing RNA was precipitated in 
100% isopropanol. Pelleted RNA was washed once in isopropanol and once in 70% ethanol, and stored 
in 50μl of diethyl decarbonate (DEPC) treated water at -80°C. RNA concentration was estimated using a 
Thermo Scientific NanoDropTM Lite. Samples were then diluted to less than 10ng/μl and analyzed on an 
Agilent 4200 Tapestation using High Sensitivity RNA ScreenTape.  Only samples with an RNA integrity 
number (RIN) number of 8.9 or greater were sequenced. Four biological replicates of wild-type and ngn-
1(ok2200) total RNA were sent to the University of Kansas Genome Sequencing Core for sequencing via 






Genome alignment and analysis of RNA sequencing data 
 RNA sequence data analysis was performed using Galaxy, an open source, web-based platform 
for data intensive biomedical research. The following workflow was used to analyze raw sequence reads: 
Reads were aligned to the latest version of the C. elegans genome at the time of analysis: C. elegans 
Feb. 2013 (WBcel235/ce11). All RNAseq analysis was performed using the Galaxy bioinformatics server 





Figure 8. Overview of comparative transcriptome bioinformatic workflow. 
 
C. elegans strain construction for transcriptome targets 
 C. elegans strains were grown on nematode growth medium plates (NGM Lite) at 20°C as 
described previously (Brenner, 1974). N2 (Bristol) was used as the wild-type strain. Table 4 shows strains 
used for transcriptome construction and target validation. These were obtained from the 
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Caenorhabditis Genetics Center or generously provided by Dr. Ian Hope. All mutant strains were 
outcrossed to a minimum of 4x. For a complete list of strains generated for this project, see 
supplemental table S1. 
Strain Genotype 
VC2084 ngn-1(ok2200) 
VC1444 unc-42 (gk598) 
VC1904 hlh-34 (gk1031) 
JY359 lim-4 (yz12) 
IB16 ceh-17 (np1) 
RB812 fax-1 (ok624) 
UL1829 unc-119 (ed3); [punc-42::GFP + unc-119(+)] 
BC15839 dpy-5 (e907); sIs14542 [rCesT01D3.2::GFP + pCeh361] 
OH96 him-5 (e1467); mgIs19 [lim-4::GFP + rol-6 (su1006)] 
UL1321 unc-119(ed3); mvEx5535 [pceh-17::GFP + unc-119(+)] 
MU1147 bwIs4 [fax-1::GFP + rol-6 (su1006)] 
 
Table 4. Mutant strains used in this project. Strains were sourced from either the Caenorhabditis Genetics Center or by request from 
individual PIs. 
 
GFP reporter imaging and analysis 
 For transcriptome target validation, wild-type and ngn-1(ok2200) mutants were crossed with 
strains containing GFP-reporter constructs for each of the target genes. The transgene reporters for hlh-
34, lim-4, and fax-1 were all integrated into the genome.  The reporters for unc-42 and ceh-17 were 
extra-chromosomal arrays, meaning that they are not integrated into the genome and are not inherited 
via Mendelian ratios. 
 L1 larvae were staged for imaging by transferring 3-fold stage embryos to a new plate, checking 
plates after 45 minutes and imaging larvae that hatched within an hour. Larva were mounted on 2% 
agarose pads, anesthetized with 1.5μl of 10mg/ml sodium azide solution in 2.0μl of M9 buffer. Larvae 
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were imaged using either a Zeiss LSM 700 confocal microscope with Zen Black imaging software, or a 
Zeiss AxioImager Z2 fluorescent microscope with Zen Blue imaging software. Images were analyzed 
using ImageJ (Fiji) software  (Rueden et al., 2017; Schindelin et al., 2012) 
 GFP expression images were scored by counting the number of GFP positive cell bodies in ngn-
1(ok2200) mutants for each of the target transgenes.  Percentages of cell bodies by region were 



















Chapter 3. RESULTS 
RNAseq and transcriptome assembly 
 We generated a comparative transcriptome of wildtype and ngn-1(ok2200) null mutants.  RNA 
was isolated from mixed-stage embryos of wildtype and ngn-1 mutants, sequenced, and analyzed for 
differential expression. This generated a list of 587 differentially expressed genes with a p-value ≤ 0.05. 
Surprisingly, the majority of these genes (n=497/587, 85%) were upregulated in the ngn-1 mutant 
background, meaning that ngn-1 is primarily acting as a transcriptional repressor during embryogenesis 
(Fig.11).  Overall the ngn-1 transcriptome had relatively low-level changes in gene expression, with the 
ngn-1 gene itself being the only target with more than +/- 4 fold-change in expression (log2FC = -3.94). 
The genes highlighted in Figure 11 are the targets chosen for further validation and will be described 
later in this chapter. When we looked at the 40 most significant hits from the differential expression 
analysis, the majority of these genes are upregulated (n=35/40) and non-transcription factor genes (n= 














Figure 11. Volcano plot of ngn-1(ok2200) transcriptome data. The y-axis shows increasing significance by p-value 
in log10 scale.  The x-axis shows change in gene expression in log2 scale. The majority of the hits are upregulated 
genes (to the right of center) meaning ngn-1 is repressing these genes during development. Downregulated genes 
(left of center) are activated or enhanced by ngn-1. The data point representing the ngn-1 gene (log2 fold-change 
= -3.94, log10 p-value = 125.2) was omitted from this graph for clarity. Highlighted genes represent transcription 











        Table 5 
Gene Base mean log2(FC) P-value P-adjusted Description 
ngn-1 
ngn-1 
283.18963 -3.942292 3.22E-130 5.26E-126 bHLH transcription factor 
hex-4 850.98712 -1.896418 9.48E-63 7.75E-59 beta-N-acetylhexosaminidase 
T02H6.12 48.851933 1.627248 5.08E-23 2.77E-19 pseudogene 
haf-6 254.02403 -1.286390 2.48E-22 1.01E-18 ATP-binding cassette transporter 
B0024.4 489.10187 1.176499 3.30E-14 1.08E-10 uncharacterized function 
ceh-17 43.712238 -1.251413 1.31E-13 3.57E-10 Phox2-like homeodomain  
pals-26 220.82078 1.173470 4.24E-13 9.89E-10 flagellum associated protein 
C30B5.6 145.35956 1.061507 5.41E-12 1.10E-08 uncharacterized function 
F13D12.3 189.54519 1.124637 1.30E-11 2.36E-08 uncharacterized function 
ZK970.7 339.85788 0.979209 6.45E-11 1.05E-07 hypodermal antigen 
T04F8.8 78.517761 0.997438 3.85E-10 5.72E-07 uncharacterized function 
Y69H2.3 455.79454 0.976368 8.34E-10 1.14E-06 uncharacterized function 
kreg-1 77.478236 0.888442 2.05E-09 2.58E-06 copper ion stress response 
F53A9.6 46.114845 0.897721 4.34E-09 5.06E-06 innate immune response 
F55H12.4 288.18944 0.932674 6.43E-09 7.00E-06 uncharacterized function 
W01F3.2 110.98765 0.839603 1.51E-08 1.55E-05 metal ion binding activity 
E04F6.8 74.872061 0.923332 2.10E-08 2.02E-05 uncharacterized function 
F16B4.4 206.03293 0.839615 2.37E-08 2.07E-05 uncharacterized function 
C08F11.7 19.517543 0.920554 2.41E-08 2.07E-05 uncharacterized function 
pals-39 33.385348 0.786044 2.74E-08 2.24E-05 flagellum associated protein 
Y47H10A.
5 
178.46191 0.780600 3.00E-08 2.33E-05 uncharacterized function 
F53A9.7 47.655146 0.817398 6.17E-08 4.59E-05 uncharacterized function 
Y58A7A.3 226.18042 0.887455 1.53E-07 1.09E-04 uncharacterized function 
nspe-7 69.227197 0.743426 1.63E-07 1.1E-04 uncharacterized function 
T14G8.4 34.375947 0.803922 1.96E-07 1.3E-04 uncharacterized function 
ptr-8 126.58227 0.751057 2.29E-07 1.4E-04 sterol sensing domain protein 
pals-37 30.186754 0.715700 4.25E-07 2.6E-04 flagellum associated protein 
F25H5.8 30.293763 0.686067 4.43E-07 2.6E-04 membrane potential modulator 
pals-27 101.70005 0.844797 5.22E-07 2.9E-04 flagellum associated protein 
tyr-6 166.03129 0.816753 6.01E-07 3.2E-04 tyrosinase 
C49G7.10 51.085617 0.722840 6.13E-07 3.2E-04 innate immune response 
cnc-11 38.987646 0.687432 6.71E-07 3.4E-04 innate immune response 
nlp-34 157.80025 0.772445 8.23E-07 4.1E-04 neuropeptide-like protein 
nlp-27 65.98537 0.672834 1.01E-06 4.9E-04 neuropeptide-like protein 
cyp-32A1 82.885435 0.749915 1.06E-06 5.0E-04  heme binding activity 
col-42 125.75969 0.698327 1.29E-06 5.9E-04 collagen - cuticle structure 
K02B7.3 1393.7226 0.427958 1.40E-06 6.2E-04 uncharacterized function 
cnc-6 69.886252 0.708441 1.65E-06 7.1E-04 innate immune response 
hlh-34 17.588648 -0.762199 1.80E-06 7.6E-04 bHLH transcription factor 
 




 To further understand ngn-1 gene regulatory network, we performed bioinformatic enrichment 
analyses (Angeles-Albores et al., 2016; Angeles-Albores et al., 2018).  Initially these were performed 
using the full list of differentially expressed genes, but the results were difficult to interpret.  However, 
by performing the analysis on the upregulated and downregulated gene-sets individually, we were able 
to uncover possible regulatory patterns. First, tissue enrichment analysis suggests that ngn-1 is 
activating or enhancing transcription primarily in neuronal tissue (Fig. 12A). This is in contrast to the 
tissue enrichment of the upregulated genes. In this case, upregulated genes were significantly enriched 
in the excretory system and the epithelial system, indicating that ngn-1 repression may be partially 
Figure 12 
Figure 12. Enrichment analysis of the ngn-1(ok2200) transcriptome data. Graphs represent the top enrichments hits by    
p-value, up to a maximum of 15 terms.  (A, C) Analysis of enrichment of tissue types in ngn-1 downregulated and 
upregulated hits, respectively. Grey bars indicate neuronal tissue. (B, D) Enrichment gene ontology terms of 
downregulated and upregulated gene sets. Bars are in decreasing order of significance by p=value. All analysis performed 




tissue specific (Fig. 12C). This tissue expression if further validated by gene ontology (GO) term 
enrichment analysis (Fig. 12, B and D). Most of the terms enriched in the downregulated dataset are 
related to transcription and DNA binding. The same is true for the upregulated dataset, where most of 
the enrichment hits are related to the cuticle, including innate immune response terms. 
 
ngn-1 regulates expression of the paired-like homeodomain transcription factor unc-42 
 Based on time of expression and tissue expression information in Wormbase, we selected a 
series of transcription factor targets from the ngn-1 transcriptome for further analysis.  The paired-like 
homeodomain transcription factor unc-42 is orthologous to several mammalian genes including human 
Prop1, and is predicted to have DNA binding activity (wormbase.org). Previous research on unc-42 in C. 
elegans has found that it positively regulates multiple genes including eat-4, aak-2, glr-1, and fax-1 
(Brockie et al., 2001; Serrano-Saiz et al., 2013; Wightman et al., 2005). Additionally, large-scale analyses 
of transcription factors suggest that unc-42 may act as a repressor as well (Fuxman Bass et al., 2016). 
unc-42 expression is significantly downregulated in the ngn-1 transcriptome, suggesting that ngn-1 is 
required to positively regulate this gene. 
 In order to validate our unc-42 transcriptome result, we crossed a transgene containing the unc-
42 promoter tagged with GFP into the ngn-1(ok2200) mutant background and imaged L1 larva via 
confocal microscopy. Wild-type worms had an average of 13 unc-42::GFP expressing head neurons 
(Fig.13B).  In our initial attempts to score the ngn-1 mutants, the images were so dim that we could only 
count a few cell bodies (Fig.13A). However, images with enhanced gain revealed more cells to be 
present. This shows that the overall expression level of unc-42 is reduced in the absence of ngn-1. 
Additionally, some cells completely lost unc-42::GFP expression, as the enhanced images showed an 
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average of only 9.5 cell bodies (Fig.13B). Together, this indicates that ngn-1 has two roles in controlling 
unc-42 expression. First, it has overall control of unc-42 expression levels by positively upregulating unc-
42 transcription, and second, it controls the number of cells that express unc-42. Whether this is 




ngn-1 regulates expression of the bHLH transcription factor hlh-34 expression 
 We performed the same GFP expression analysis on another transcriptome target, hlh-34, which 
is predicted to code for a basic helix-loop-helix transcription factor. hlh-34 is a expressed in the nervous 
system and the intestine during C. elegans embryogenesis, and is an ortholog of the human NPAS1 
protein coding gene (wormbase.org, Grove et al., 2009).  NPAS genes are enhanced in brain tissue, and 
defects in NPAS gene function are implicated in obesity and regulation of the circadian clock (Zhou et al., 
1997).  
Figure 13. Images and analysis of ngn-1’s regulation of unc-42  A) Expression of unc-42::GFP in L1 larva. Images are 40x 
magnification. Anterior is to the left. Enhanced images have increased GFP gain. B) The number of GFP+ cell bodies in 
wild-type and ok2200 mutants. Each black dots represents one day of data collection (n=14+).  **p≤0.001 
 
Figure 13 




 Iniitially, we experienced apparent difficulty in generating a homozygous ngn-1(ok2200); hlh-
34::GFP strain. Worms homozygous for ok2200 appeared to consistantly lay very few GFP-positive 
progeny (approximately 1 in 20). To confirm that we had indeed built a ngn-1(ok2200); sIs15452 double 
homozygote, we crossed this strain with wild-type males and scored F1 male progeny only, as F1 males 
must be cross-progeny by definition (Fig. 14C). 100% of F1 males were GFP-positive, confirming the 
identity of our strain generation (Fig. 14B). From this we conclude that ngn-1 is almost exclusively 
required for hlh-34 transcription during development, but that there are low-level, bypass 
transcriptional activation pathways that can stochastically activate hlh-34 transcription in around 5% of 





Figure 14. Images and analysis of ngn-1’s regulation of hlh-34 A) Expression of hlh-34::GFP in L1 larva. Images are 40x 
magnification. Anterior is to the left. B) The number of GFP+ cell bodies in wild-type, ok2200 -/+, and ok2200 -/-**p≤0.001. 




 A       B            C 
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Chapter 3. DISCUSSION 
ngn-1 acts primarily a repressor of gene expression 
 The results of our comparative transcriptome generation and analysis characterize the proneural 
transcription factor ngn-1 as having a primarily repressive role during C. elegans embryonic 
development. Tissue and GO term enrichment analysis indicate that ngn-1 repressed genes are largely 
associated with non-neuronal tissues, such as excretory tissue and epithelial tissue. The C. elegans 
excretory system consists of five cells located in close proximity to the nerve ring: one pore cell, one 
duct cell, one canal cell (excretory cell), and a fused pair of gland cells (Altun and Hall, 2009a). This 
system is critical for the worm’s viability and suspected to function as a proto-renal system, regulating 
osmotic function and secretion of waste products, although the function(s) of this secretion system is 
largely unknown. The embryonic cells that make up the epithelial hypodermis undergo drastic cell 
migrations and morphological changes that are critical for the development and viability embryo (Altun 
and Hall, 2009b). These results are in line with our observations of an apparent loss of epithelial integrity 
and rupture during embryonic elongation (Fig. 4). Additionally there are multiple enriched terms relating 
to the cuticle, including specifically the first larval stage cuticle that is formed during embryonic 
elongation (Altun and Hall, 2009b). 
 It is important to note that, given the nature of this experiment and ngn-1’s role in cell 
differentiation and specification, we are unable to determine whether the fold-change observed in the 
ngn-1 mutant transcriptome is due to an increase/decrease in transcription of these genes, or whether 
there is a greater/fewer number of cells expressing these genes. Our future work includes generating a 
full lineage of ngn-1, as this would greatly increase our ability to identify additional targets and begin to 
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validate the mechanisms of ngn-1 regulation. Preliminary manual identification of ngn-1::GFP expressing 
cells indicate that it begins expression at the 12-cell stage embryo in just 2 cells: MSpa and MSpp, 
followed about 15 minutes later by onset of expression in the ABpra and ABprp cells (M. L. Hudson, 
unpublished observations). This suggests that while ngn-1 expression is predominantly expressed in the 
anterior of the embryo throughout most of development in neuroectodermal AB-lineage cells, as 
previously reported (Grove et al., 2009; Nakano, 2010), the very early expression of ngn-1 in posterior 
MS cells may correlate with its function as a transcriptional repressor in non-neuronal systems. 
 
ngn-1 activates transcription factors regulating nervous system development 
 The results of expression analysis in ngn-1(ok2200) mutants suggest that ngn-1 acts an activator 
or transcriptional enhancer of the transcription factors unc-42 and hlh-34 during embryogenesis.  We 
identified additional neuronal-associated transcription factors, ceh-17, lim-4, and lin-11, that we are 
currently validating using similar methods. Our results regarding changes in unc-42 expression in an ngn-
1(ok2200) mutant background are further supported by the appearance of fax-1 in our transcriptome. 
Previous research has identified that unc-42 functions in parallel pathways with fax-1 in some neurons, 
but positively regulates fax-1 in others, specifically in the SIBV/D, AVK interneurons (Wightman et al., 
2005). Our transcriptome analysis found a reduction in fax-1 expression similar to the reduction in unc-
42 (unc-42 log2FC= -0.416, fax-1 log2FC = -0.394), suggesting that the change in fax-1 expression is in an 
unc-42 dependent pathway. Triple mutant analysis will confirm this. The AVK interneurons are predicted 
to regulate the coordination of muscle movement, while the SIB interneurons are required for the 
proper anterior/posterior placement of the nerve ring, both phenotypes were observed in ngn-
1(ok2200) mutants as described in Chapter 2 (Kennerdell et al., 2009; Wightman et al., 2005). 
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CHAPTER 4 -- Integration of the thesis research 
 The research generated in this project represents the synthesis of multiple biological disciplines 
including: genetics, developmental biology, molecular biology, and computational biology. Utilizing 
bioinformatics, we were able to generate a list of targets we otherwise might not have identified as 
candidates of neurogenin regulation.  We then combined these results with in vivo analysis using 
classical genetics and developmental methods to further investigate these targets. Through this multi-
disciplinary approach, the results of this project address questions from a molecular to an organismal 
scale.  In addition to integrative methods, we have generated a transcriptome of ngn-1 during C. elegans 
embryogenesis.  This data will be useful to researchers across fields of biology, including evolutionary 
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Supplemental 1 – Table of all strains used and built for this project 
Strain Genotype 
OH904 otIs33 [pkal-1::GFP] 
OH99 mgIs18 [pttx-3::GFP] 
CZ1200 juIs76 [unc-25p::GFP + lin-15(+)]; lin-15(n765) 
RW10055 unc-119(ed3); stIs10055 [cnd-1(3.2kb)::HIS-24::mCherry + unc-119(+)] 
ST65 ncIs13 [ajm-1::gfp] 
MT19703 nIs394 [ngn-1::GFP + lin-15(+)]; lin15AB (n765) 
VL4 unc-119 (ed3); wwEx37 [ngn-1::GFP + unc-119(+)] 
EM67 mab-20 (bx24); him-5 (e1490) 
CX3198 sax-3 (ky123) 
IC476 sax-3 (ky123); quEx99 [sax-3(minigene) + odr-1::RFP] 
VC1444 unc-42 (gk598) 
VC1904 hlh-34 (gk1031) 
JY359 lim-4 (yz12) 
IB16 ceh-17 (np1) 
RB812 fax-1(ok624) 
UL1829 unc-119(ed3); [punc-42::GFP + unc-119(+)] 
BC15839 dpy-5(e907); sIs14542 [rCesT01D3.2::GFP + pCeh361] 
KQ1865 N2; ftEx1074 [Phlh-34::mcherry; rol-6 (su1006)] 
OH96 mgIs19 [lim-4::GFP + rol-6 (su1006)]; him-5 (e1467) 
UL1321 unc-119(ed3); mvEx5535 [pceh-17::GFP + unc-119(+)] 
MU1147 bwIs4 [fax-1::GFP + rol-6(su1006)] 
ATL126 cnd-1 (ju29); ngn-1 (ok2200); otIs33 [pkal-1::GFP] 6x outcross 
ATL127 ngn-1 (ok2200) mgIs18 [pttx-3::GFP] 4x outcross 
ATL135 vab-1(dx31); mgIs18 [pttx-3::GFP] 
ATL140 efn-4(bx80) mgIs18 [pttx-3::GFP] 
ATL143 ngn-1(ok2200) 6x outcross 
ATL150 daf-18(bx480) mgIs18 [pttx-3::GFP] 
ATL156 daf-18(ok480); ngn-1 (ok2200) mgIs18 [pttx-3::GFP] 
ATL163 efn-4(bx80) ngn-1(ok2200) mgIs18 [pttx-3::GFP] 
ATL164 mab-20(bx24); mgIs18 [pttx-3::GFP] 
ATL166 vab-1(dx31)/mIn1 mIs14; ngn-1 (ok2200) mgIs18 [pttx-3::GFP] 
ATL167 mab-20(bx24); ngn-1(ok2200) mgIs18 [pttx-3::GFP] 
ATL184 ngn-1(ok2200); sax-3(ky123); quEx99 [sax-3(minigene) + odr-1::RFP] 
ATL185 nIs394 [ngn-1::GFP + lin-15(+)]; ngn-1(ok2200) 
ATL188 sdn-1(zh20); ngn-1(ok2200) mgIs18 [pttx-3::GFP] 
ATL189 juIs76 [unc-25p::GFP + lin-15(+)] 8x outcross 
ATL190 sdn-1(zh20); mgIs18 [pttx-3::GFP] 
ATL191 ngn-1(ok2200); [pceh-17::GFP + unc-119 (+)] 
ATL192 ngn-1(ok2200); [punc-42::GFP + unc-119 (+)] 
ATL193 bwIs4 [fax-1::GFP + rol-6(su1006)] 4x outcross 
ATL208 ngn-1(ok2200); stIs10055 [cnd-1(3.2kb)::HIS-24::mCherry + unc-119(+)] 
ATL209 ngn-1(ok2200); wwEx37 [ngn-1::GFP + unc-119(+)] 
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ATL210 stIs10055 [cnd-1(3.2kb)::HIS-24::mCherry + unc-119(+)]; wwEx37 [ngn-1::GFP + unc-
119(+)] ATL211 wwEx37 [pngn-1::GFP + unc-119(+)] 4x outcross 
ATL212 ngn-1(ok2200); bwIs4 [fax-1::GFP + rol-6(su1006)] 
ATL220 ngn-1(ok2200); juIs76 [punc-25::GFP] 
ATL221 cnd-1(ju29); mgIs18 [pttx-3::GFP] 
ATL222 cnd-1(ju29); ngn-1(ok2200) mgIs18 [pttx-3::GFP] 
ATL238 mgIs19 [lim-4::GFP + rol-6(su1006)] 
ATL239 ngn-1(ok2200); mgIs19 [lim-4::GFP + rol-6(su1006)] 
ATL241 lim-4(yz12) 4X outcross 
ATL249 ngn-1(ok2200); sIs14542 [rCesT01D3.2::GFP + pCeh361] Line A 
ATL250 ngn-1(ok2200); sIs14542 [rCesT01D3.2::GFP + pCeh361] Line B 
ATL251 ngn-1(ok2200); sIs14542 [rCesT01D3.2::GFP + pCeh361] Line C 
ATL252 fax-1(ok624) 4x outcross 
ATL253 unc-42(gk598) 4x outcross 
ATL254 ngn-1(ok2200); ncIs13 [ajm-1::GFP] 
ATL255 [punc-42::GFP + unc-119 (+)]; ftEx1074[Phlh-34::mcherry; rol-6 (su1006)] 
 
 
 
 
